193 related articles for article (PubMed ID: 17701883)
1. Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism.
Katircibasi MT; Deniz F; Pamukcu B; Binici S; Atar I
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):376-9. PubMed ID: 17701883
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease.
Berker D; Işik S; Canbay A; Aydin Y; Tütüncü Y; Delibaşi T; Güler S
Anadolu Kardiyol Derg; 2009 Aug; 9(4):298-303. PubMed ID: 19666432
[TBL] [Abstract][Full Text] [Related]
3. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism.
Aras D; Maden O; Ozdemir O; Aras S; Topaloglu S; Yetkin E; Demir AD; Soylu MO; Erdogan MF; Kisacik HL; Korkmaz S
Int J Cardiol; 2005 Mar; 99(1):59-64. PubMed ID: 15721500
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of P-wave duration and dispersion in patients with mitral stenosis.
Guntekin U; Gunes Y; Tuncer M; Gunes A; Sahin M; Simsek H
Pacing Clin Electrophysiol; 2008 Dec; 31(12):1620-4. PubMed ID: 19067816
[TBL] [Abstract][Full Text] [Related]
5. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion.
Boriani G; Diemberger I; Biffi M; Camanini C; Valzania C; Corazza I; Martignani C; Zannoli R; Branzi A
Int J Cardiol; 2005 Jun; 101(3):355-61. PubMed ID: 15907401
[TBL] [Abstract][Full Text] [Related]
6. P-wave duration and dispersion in patients with metabolic syndrome.
Yasar AS; Bilen E; Bilge M; Ipek G; Ipek E; Kirbas O
Pacing Clin Electrophysiol; 2009 Sep; 32(9):1168-72. PubMed ID: 19719494
[TBL] [Abstract][Full Text] [Related]
7. Assessment of P wave duration and dispersion in Parkinson's disease.
Kocer A; Karakaya O; Barutcu I; Batukan Esen O; Kargin R; Mayda Domac F
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):718-23. PubMed ID: 16600454
[TBL] [Abstract][Full Text] [Related]
8. The effects of trimetazidine on p-wave duration and dispersion in heart failure patients.
Gunes Y; Tuncer M; Guntekin U; Akdag S; Gumrukcuoglu HA
Pacing Clin Electrophysiol; 2009 Feb; 32(2):239-44. PubMed ID: 19170914
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term beta-blocker therapy on P-wave duration and dispersion in patients with rheumatic mitral stenosis.
Erbay AR; Turhan H; Yasar AS; Bicer A; Senen K; Sasmaz H; Sabah I; Yetkin E
Int J Cardiol; 2005 Jun; 102(1):33-7. PubMed ID: 15939096
[TBL] [Abstract][Full Text] [Related]
10. The effect of conversion type on P wave dispersion in patients with atrial fibrillation.
Dogan A; Varol E; Ozaydin M; Acar G; Gedikli O; Altinbas A; Kinay O; Nazli C; Kahraman H; Ergene O
Minerva Cardioangiol; 2008 Oct; 56(5):477-82. PubMed ID: 18813183
[TBL] [Abstract][Full Text] [Related]
11. Perindopril decreases P wave dispersion in patients with stage 1 hypertension.
Ozben B; Sumerkan M; Tanrikulu AM; Papila-Topal N; Fak AS; Toprak A
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):85-90. PubMed ID: 19502255
[TBL] [Abstract][Full Text] [Related]
12. [Detection of patients at risk for paroxysmal atrial fibrillation (PAF) by signal averaged P wave, standard ECG and echocardiography].
Michałkiewicz D; Dziuk M; Kamiński G; Olszewski R; Cholewa M; Cwetsch A; Markuszewski L
Pol Merkur Lekarski; 2006 Jan; 20(115):69-72. PubMed ID: 16617740
[TBL] [Abstract][Full Text] [Related]
13. Effect of slow coronary flow on P-wave duration and dispersion.
Turkmen M; Barutcu I; Esen AM; Karakaya O; Esen O; Basaran Y
Angiology; 2007; 58(4):408-12. PubMed ID: 17652223
[TBL] [Abstract][Full Text] [Related]
14. Atrial fibrillation after non-cardiac surgery: P-wave characteristics and Holter monitoring in risk assessment.
Materazzo C; Piotti P; Mantovani C; Miceli R; Villani F
Eur J Cardiothorac Surg; 2007 May; 31(5):812-6. PubMed ID: 17337197
[TBL] [Abstract][Full Text] [Related]
15. The effect of rapid blood pressure control on P-wave dispersion in hypertensive urgency.
Karaca I; Durukan P; Dagli N; Yavuzkir M; Ikizceli I; Balin M
Adv Ther; 2008 Dec; 25(12):1303-14. PubMed ID: 19043679
[TBL] [Abstract][Full Text] [Related]
16. Improvement of P wave dispersion after cardiac resynchronization therapy for heart failure.
Ding L; Hua W; Zhang S; Chu J; Chen K; Wang F; Chen X
J Electrocardiol; 2009; 42(4):334-8. PubMed ID: 19539810
[TBL] [Abstract][Full Text] [Related]
17. Prolonged P wave dispersion in pre-diabetic patients.
Karabag T; Aydin M; Dogan SM; Cetiner MA; Sayin MR; Gudul NE; Kucuk E
Kardiol Pol; 2011; 69(6):566-71. PubMed ID: 21678292
[TBL] [Abstract][Full Text] [Related]
18. P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment.
Guntekin U; Gunes Y; Simsek H; Tuncer M; Arslan S
Indian Pacing Electrophysiol J; 2009 Sep; 9(5):251-9. PubMed ID: 19763193
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline.
De Bacquer D; Willekens J; De Backer G
Am J Cardiol; 2007 Sep; 100(5):850-4. PubMed ID: 17719332
[TBL] [Abstract][Full Text] [Related]
20. Association of P wave duration and dispersion with the risk for atrial fibrillation: practical considerations in the setting of coronary artery disease.
Turgut O; Tandogan I; Yilmaz MB; Yalta K; Aydin O
Int J Cardiol; 2010 Oct; 144(2):322-4. PubMed ID: 19285738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
